Valeant Pharmaceuticals T/L (11/18)
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Valeant Pharmaceuticals T/L (11/18) Bank Loan, CUSIP 0LX177019.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Valeant Pharmaceuticals T/L (11/18) Bank Loan, CUSIP 0LX177019.